GlassScriptPhysician profile
Charles V Barrett
NPI 1881637759
$2,402.95
in general payments reported to CMS, 2019-2025
22 companies · $448 in 2025
The $448 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,140 · 2020: $66.70 · 2021: $37.60 · 2022: $212 · 2023: $244 · 2024: $254 · 2025: $448.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $687.54 | 2019-2025 | Xtampza, Belbuca |
| Steris Corporation | $599.00 | 2019 | |
| Globus Medical, INC. | $206.95 | 2025 | Senza |
| Medtronic, INC. | $183.13 | 2022-2024 | Intellis Adaptivestim |
| Nevro Corp. | $127.83 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $119.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $61.12 | 2019 | |
| Pfizer INC. | $53.42 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $41.84 | 2019 | |
| Amgen INC. | $39.07 | 2019 | |
| Grt US Holding, INC. | $37.60 | 2021 | |
| Abbott Laboratories | $35.10 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $34.06 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.84 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $24.69 | 2022-2023 | Seglentis |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $24.33 | 2019 | |
| Tonix Medicines, INC. | $21.96 | 2025 | Tonmya |
| Si-Bone, INC. | $17.53 | 2024 | |
| Scilex Pharmaceuticals INC. | $17.20 | 2019 | |
| Upsher-Smith Laboratories LLC | $16.86 | 2019 | |
| Lilly USA, LLC | $16.32 | 2019 | |
| Pacira Therapeutics, INC. | $12.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.